Department of Pediatrics, Université de Sherbrooke, Quebec, Canada.
Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Quebec, Canada.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2391625. doi: 10.1080/21645515.2024.2391625. Epub 2024 Aug 26.
The COVID-19 pandemic highlighted Vaccine Hesitancy (VH) as an accelerating global phenomenon that must be addressed. According to the WHO, thirty to fifty percent of the world's population are VH. Motivational Interviewing (MI) is an evidence-based communication style demonstrated to significantly reduce VH. MI guides people toward change through the expression of empathy and by respecting an individual's autonomy. Healthcare providers (HCPs) are the primary implementors of vaccine policies and the most trusted advisors and influencers of vaccination intention at the individual patient level. Training HCPs in MI is one of the most effective strategies to overcome VH. Many countries are currently implementing HCP training programs and population-based MI interventions to improve vaccine uptake. MI conversations are 'the heart' of vaccine decision-making processes. Understanding individual patient-level drivers of hesitancy allows clinicians to efficiently provide tailored, accurate information that reinforces a person's own motivation and confidence in their own decision. This paper describes a 4-step practical framework designed to support HCPs in their dialogue with vaccine-hesitant patients. (1) to establish a trustful relationship and safety to freely express opinions, beliefs, and knowledge gaps; (2) most to the individual; (3) to co-build accurate knowledge in order to guide the individual toward vaccine intention (4) to validate an individual's decision-making autonomy. We believe that our pragmatic approach can contribute to greater acceptability of COVID-19 and other vaccines, and enable rapid deployment of practical MI skills across care systems.
新型冠状病毒肺炎大流行凸显了疫苗犹豫(VH)是一种加速的全球现象,必须加以解决。根据世界卫生组织的数据,全球有 30%至 50%的人口对疫苗持犹豫态度。动机性访谈(MI)是一种基于证据的沟通方式,已被证明可以显著降低 VH。MI 通过表达同理心和尊重个人自主权来引导人们做出改变。医疗保健提供者(HCP)是疫苗政策的主要执行者,也是个体患者层面疫苗接种意愿最值得信赖的顾问和影响者。培训 HCP 掌握 MI 是克服 VH 的最有效策略之一。许多国家目前正在实施 HCP 培训计划和基于人群的 MI 干预措施,以提高疫苗接种率。MI 对话是疫苗决策过程的“核心”。了解个体患者层面的犹豫因素,使临床医生能够高效地提供量身定制的、准确的信息,增强个人对自己决策的动机和信心。本文描述了一个 4 步实用框架,旨在支持 HCP 与疫苗犹豫患者进行对话。(1)建立信任关系和安全感,以便自由表达意见、信念和知识差距;(2)最大限度地关注个体;(3)共同构建准确的知识,以引导个体产生疫苗接种意愿;(4)验证个人的决策自主权。我们相信,我们的实用方法可以促进对 COVID-19 和其他疫苗的更大接受度,并使实用的 MI 技能能够在整个医疗系统中快速部署。